NVS EV/EBITDA: current value, 10-year range and year-by-year history
Cash & Leverage
NVS's ev/ebitda is higher than 95% of the last 10 years.
EV/EBITDA History
NVS EV/EBITDA by year
Yearly range of NVS’s ev/ebitda from 2016 to 2026. Over the full period it ranged from 5.7 to 16.8, averaging 12.0.
| Year | Low | Average | High | Year-end |
|---|---|---|---|---|
| 2026 | 12.8 | 14.6 | 15.9 | 15.6 |
| 2025 | 10.3 | 11.6 | 12.8 | 12.8 |
| 2024 | 10.4 | 12.4 | 14.1 | 10.4 |
| 2023 | 11.4 | 12.7 | 14.0 | 12.4 |
| 2022 | 5.7 | 6.2 | 6.9 | 6.7 |
| 2021 | 6.2 | 12.2 | 14.0 | 6.2 |
| 2020 | 11.0 | 13.4 | 14.9 | 13.5 |
| 2019 | 8.9 | 12.1 | 15.2 | 14.3 |
| 2018 | 7.8 | 11.2 | 16.0 | 9.1 |
| 2017 | 10.8 | 14.6 | 16.8 | 16.0 |
| 2016 | 10.9 | 11.9 | 13.3 | 11.6 |
Get notified when NVS EV/EBITDA crosses a threshold
Free — one alert setup, notifications by push, Telegram, or Discord.
An acquisition-style valuation multiple: Enterprise Value (market cap + net debt) divided by operating earnings before accounting adjustments. Compares companies fairly regardless of their capital structure.
(Market Cap + Net Debt) / EBITDAUnlike P/E, this metric accounts for debt — two companies with identical operations but different leverage will show similar EV/EBITDA. Low vs history suggests the total business is modestly priced.
- EBITDA ignores capital expenditure. For asset-heavy businesses (airlines, mining, utilities), this understates the real cost — use EV/EBIT or EV/FCF instead.
- Large acquisitions temporarily spike net debt and can distort the ratio for 1–2 years during integration.
Is NVS EV/EBITDA High or Low Right Now?
Novartis AG's EV/EBITDA is currently 15.6, which is near historic high relative to its 10-year historical range. The 10-year median EV/EBITDA for NVS is approximately 12.5. See all NVS valuation metrics →
Unlock 10y, 15y, 20y, and 30y history with peer comparison and CSV export.